SYROS PHARMACEUTICALS INC's ticker is and the CUSIP is 87184Q206. A total of 55 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $325,152 | -76.7% | 63,014 | -75.9% | 0.00% | -100.0% |
| Q1 2024 | $1,396,794 | +3357.5% | 261,083 | +1935.7% | 0.00% | – |
| Q2 2023 | $40,399 | +19229.7% | 12,825 | -83.6% | 0.00% | – |
| Q1 2023 | $209 | -36.3% | 78,336 | -14.4% | 0.00% | – |
| Q4 2022 | $328 | -99.9% | 91,473 | +31.4% | 0.00% | – |
| Q3 2022 | $448,000 | – | 69,634 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,786,427 | $9,557,384 | 1.48% |
| Bain Capital Life Sciences Investors, LLC | 2,749,808 | $14,711,473 | 1.18% |
| Opaleye Management Inc. | 787,545 | $4,212,831 | 0.92% |
| Omega Fund Management, LLC | 251,270 | $1,344,295 | 0.87% |
| Flagship Pioneering Inc. | 1,293,849 | $6,922,093 | 0.45% |
| Knott David M Jr | 233,000 | $1,247 | 0.44% |
| Blue Owl Capital Holdings LP | 340,855 | $1,823,574 | 0.36% |
| Artal Group S.A. | 2,505,013 | $13,401,820 | 0.34% |
| Avidity Partners Management LP | 1,673,538 | $8,953,428 | 0.29% |
| DAFNA Capital Management LLC | 135,850 | $726,798 | 0.16% |